Announcements Trials
Browse Landscape

Phase

Phase 2 63Phase NA 51Phase 3 41Phase 1 26Phase 1/2 13Phase EARLY_PHASE1 3Phase 4 2Phase 2/3 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Deglutition Disorders 1Adenocarcinoma 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Interventional × Brachytherapy × Clear all
NCT06288373 2024-10-30

Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

Tongji Hospital

Phase 2/3 Recruiting
440 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT01786278 2013-02-07

BRASTEGAC

Medical University of Lublin

Phase 2/3 Unknown
80 enrolled

Adenocarcinoma, Deglutition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡